Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Ulcerative ColitisReview · 2011 · 1,110 citations
2. 2Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and healthCross-Sectional Study · 2011 · 347 citations
3. 3Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisRCT · 2013 · 2,892 citations
4. 4Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and futureClinical Trial · 2013 · 91 citations
5. 5Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapyReview · 2011 · 117 citations